Cleared Special

K112245 - XTRA

K112245 is an FDA 510(k) clearance for XTRA, manufactured by Sorin Group Italia S.R.L.. The device is a Class 2 Anesthesiology device with product code CAC cleared through the Special 510(k) pathway after a 33-day FDA review.

K112245 · Sorin Group Italia S.R.L. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
33d
Days
Class 2
Risk

K112245 is an FDA 510(k) clearance for the XTRA. Classified as Apparatus, Autotransfusion (product code CAC), Class II - Special Controls.

Submitted by Sorin Group Italia S.R.L. (Waltham, US). The FDA issued a Cleared decision on September 6, 2011 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5830 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Sorin Group Italia S.R.L. devices

FDA 510(k) Submission Details - K112245

510(k) Number K112245 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2011
Decision Date September 06, 2011
Days to Decision 33 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
107d faster than avg
Panel avg: 140d · This submission: 33d
Pathway characteristics
Modification to existing cleared device.

CAC Device Classification - Class 2, Special Controls

Product Code CAC Apparatus, Autotransfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAC Apparatus, Autotransfusion

All 145
Devices cleared under the same product code (CAC) and FDA review panel - the closest regulatory comparables to K112245.
PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM
K130043 · Teleflexmedical, Inc. · Feb 2013
ORTHOPAT ADVANCE PERIOPERATIVE AUTOTRANSFUSION SYSTEM
K122262 · Haemonetics Corp. · Oct 2012
CELL SAVER ELITE
K120586 · Haemonetics Corp. · May 2012
XVAC
K110782 · Sorin Group Italia S.R.L. · Apr 2011
HAEMONETICS CELL SAVER ELITE AUTOTRANSFUSION SYSTEM
K101907 · Haemonetics Corp. · Dec 2010
PREASSEMBLED SURGICAL WASH SET
K103202 · Sorin Group Italia S.R.L. · Nov 2010